Quality of Life Outcomes in Apollo, the Phase 3 Trial of the Rnai Therapeutic Patisiran in Patients with Hereditary Transthyretin-Mediated Amyloidosis
AuthID
P-00R-VY6
P-00R-VY6
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service